Kerneis, Mathieu
Nafee, Tarek
Yee, Megan K.
Kazmi, Hassan A.
Datta, Sudarshana
Zeitouni, Michel
Afzal, M. Khurram
Jafarizade, Mehrian
Walia, Sargun S.
Qamar, Iqra
Pitliya, Anmol
Kalayci, Arzu
Al Khalfan, Fahad
Gibson, C. Michael
Article History
First Online: 13 March 2019
Compliance with Ethical Standards
:
: Mathieu Kerneis has received research grant from Federation Francaise de Cardiologie and Institut Servier.C. Michael Gibson reports grants from Angel Medical Corporation; grants and personal fees from Bayer Corp., CSL Behring, Janssen Pharmaceuticals, and Johnson & Johnson Corporation; personal fees from The Medicines Company, Boston Clinical Research Institute, Cardiovascular Research Foundation, Eli Lilly and Company, Gilead Sciences, Inc., Novo Nordisk, Web MD, UpToDate in Cardiovascular Medicine, Portola Pharmaceuticals, Amarin Pharma, Amgen, Boehringer Ingelheim, Chiesi, Merck & Co, Inc., PharmaMar, Sanofi, Somahlution, St. Francis Hospital, Verreseon Corporation, Boston Scientific, Duke Clinical Research Institute, Impact Bio, LTD, MedImmune, Medtelligence, Microport, PERT Consortium, and nference; and non-financial support from Baim Institute.Tarek Nafee has received research grant support and consulting fees from Portola Pharmaceuticals Inc.Megan K. Yee, Hassan A. Kazmi, Sudarshana Datta, Michel Zeitouni, M. Khurram Afzal, Mehriam Jafarizade, Sargun S. Walia, Iqra Qamar, Anmol Pitliya, Arzu Kalayci, and Fahad Al Khalfan declare that they have no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.